These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9480140)

  • 1. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
    Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
    Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDAVP's shortening of the bleeding time seems due to plasma von Willebrand factor.
    Beck KH; Bleckmann U; Mohr P; Kretschmer V
    Semin Thromb Hemost; 1995; 21 Suppl 2():40-3. PubMed ID: 7660156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
    Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
    J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin effect on acetylsalicylic acid impaired platelet function.
    Beck KH; Mohr P; Bleckmann U; Schweer H; Kretschmer V
    Semin Thromb Hemost; 1995; 21 Suppl 2():32-9. PubMed ID: 7660155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.
    Rao AK; Ghosh S; Sun L; Yang X; Disa J; Pickens P; Polansky M
    Thromb Haemost; 1995 Oct; 74(4):1071-8. PubMed ID: 8560416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utility of desmopressin in 4 cases of thrombocytopathies associated with giant platelets].
    Martínez-Murillo C; Quintana-González S; Ambriz-Fernández R; Arzate-Hernández G; Gutiérrez-Romero M; Gaminio-Gómez E
    Rev Invest Clin; 1997; 49(4):281-6. PubMed ID: 9707993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
    Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
    Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy.
    Wieding JU; Matern J; Köstering H; Wermes C; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):441-8. PubMed ID: 16149022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL; Howard MA; White JG; Menon C; Berry EW
    Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
    Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
    Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
    Brassard JA; Meyers KM
    Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time.
    Wadanoli M; Sako D; Shaw GD; Schaub RG; Wang Q; Tchernychev B; Xu J; Porter TJ; Huang Q
    Thromb Haemost; 2007 Aug; 98(2):397-405. PubMed ID: 17721623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of desmopressin (DDAVP) on blood platelet parameters in vivo and in vitro].
    Kätzel R; Dietzel H; Selle B; Taube C
    Z Gesamte Inn Med; 1992 Jul; 47(7):303-7. PubMed ID: 1496839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet hyporesponsiveness to acetylsalicylic acid can be transferred by plasma in humans.
    Anger K; Kempfert J; Kostelka M; Mohr FW; Dhein S
    Pharmacology; 2010; 85(4):241-7. PubMed ID: 20332671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.